day101
Showing 1 - 4 of 4
Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma Trial in San Francisco (Nivolumab, DAY101)
Not yet recruiting
- Craniopharyngioma, Child
- +2 more
- Nivolumab
- DAY101
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 15, 2022
Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)
Not yet recruiting
- Low-grade Glioma
- DAY101
- Chemotherapeutic Agent
- (no location specified)
Oct 3, 2022
Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)
Recruiting
- Melanoma
- Solid Tumor
- DAY101
- Pimasertib Hydrochloride
-
Los Angeles, California
- +13 more
Jul 27, 2022
Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)
Recruiting
- Low-grade Glioma
- Advanced Solid Tumor
- DAY101
-
San Francisco, California
- +35 more
May 25, 2022